Tradestie Institutional Equity Comparison Engine

FRMM vs ADTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ADTX Overall Edge

ADTX Captures Institutional Edge (2โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aditxt, Inc. Common Stock (ADTX) driven by superior Valuation, Growth & Margin while FRMM counters with relative strength in Momentum & Technical. Fundamentally, FRMM trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ADTX at 0.3x Forward P/E and -35873.5% operating margin (+1094.4% YoY). In options structure, FRMM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ADTX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ADTX
FRMM N/M vs ADTX 0.3x Fwd P/E
Growth & Margin Winner ADTX
Op Margin N/A vs -35873.5% ยท YoY N/A vs +1094.4%
Momentum & Technical Winner FRMM
1Y -44.5% vs -99.3% ยท 52W Pos 3% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
FRMM US Equity
FRMM
Institutional Equity
$1.92
-4.48% 1D
Market Cap N/A
1M Return -42.34%
1Y Return -44.51%
Forward P/E N/M
Unified AI Score
42.5 / 100 HOLD
Tech 35.0 Fund 44.0 Flow 50.0 Mom 55.0
ADTX NASDAQ
Aditxt, Inc. Common Stock
Pharmaceutical Preparations
$0.01
-77.22% 1D
Market Cap $34,023
1M Return -98.15%
1Y Return -99.29%
Forward P/E 0.3x
Unified AI Score
50.4 / 100 HOLD
Tech 45.0 Fund 51.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FRMM -44.51% ADTX -99.29% Spread: +144.55 pp (FRMM Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
FRMM TTM Op. Margin: N/A ADTX TTM Op. Margin: -35873.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FRMM vs ADTX. Trailing 12-month operating profitability (FRMM N/A vs ADTX -35873.5%) and valuation multiples (FRMM N/M vs ADTX 0.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FRMM (2) vs ADTX (8)
Institutional Metric FRMM ADTX Criterion Row Winner
Market Capitalization Scale N/A $34,023 Larger Scale ADTX
Trailing P/E Ratio Valuation N/M 0.3x Lower Multiple ADTX
Forward P/E Ratio Valuation N/M 0.3x Lower Multiple ADTX
Revenue Growth (YoY) Growth N/A +1094.4% Higher Growth ADTX
Operating Margin (TTM) Profitability N/A -35873.5% Higher Margin ADTX
Net Profit Margin Profitability N/A 0.0% Higher Margin ADTX
Return on Equity (ROE) Capital Efficiency N/A -699.1% Higher ROE ADTX
52-Week Range Position Momentum 3% ($2โ€“$7) 0% ($0โ€“$7) Stronger Trend FRMM
Beta / 30D Volatility Risk Regime 2.28ฮฒ ยท 107% Vol 13.77ฮฒ ยท 831% Vol Lower Realized Risk FRMM
Unified Institutional Score Composite Signal 42.5 / 100 (HOLD) 50.4 / 100 (HOLD) Higher Composite ADTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FRMM vs ADTX Buy Guide
FRMM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FRMM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ADTX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ADTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FRMM nor ADTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.